Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-22-000009

Options or other derivatives

  • Chief Scientific Officer acquired 285,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sofia Michael J. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +285,000 $2.81 $800,850 285,000 D
Loading xslF345X03/wf-form4_164271925075900.xml…